Bibliography for: "MAP Pharma, AstraZeneca will develop asthma drug"

"MAP Pharma, AstraZeneca will develop asthma drug". Chain Drug Review. FindArticles.com. 29 Nov, 2009. http://findarticles.com/p/articles/mi_hb3007/is_2_31/ai_n31414758/

Chain Drug Review

View more issues:

Articles in Jan 19, 2009 issue of Chain Drug Review

• Drug chains show resilience in face of economic woes
• Huge deficits cast shadow on Medicare
• Wal-Mart offers a new 'solution'
• SDM appoints Lukow CFO
• Walgreens to cut 1,000 management positions
• Rx ownership law in N.D. comes under fire
• Rite Aid will help people limit weight
• AG makes acquisition, extends sway in humorous cards
• P&G promotion helps children
• Numark pledges no price hikes this year
• LifeStyles introduces extra-sensitive condom
• Walgreens earnings take a hit during first quarter
• Store growth plans scaled back further
• Chain responding to thrifty shoppers, COO says
• Rite Aid has many reasons for optimism
  by David Pinto
• Pivotal year ahead for Rx industry leaders
  by Jeffrey Woldt
• Kit aids gluten intolerance
• Snack helps satisfy dieters
• Supplements offer economical health option
• Aurora promotes wider use of vitamin D
• Older adults seek alternatives
• Drug retailers hold a big edge
• Weight control category looks for a rebound
• Bausch & Lomb
• Everlast Sports Nutrition
• Natrol Inc
• Nutrition 21
• David Bell
• Mike Coughlin
• Jerry Fagen
• Mark Gregory
• Preston Hale
• Doyle Jensen
• Stanton McComb
• Tom Rhoads
• Christopher Thomsen
• New guidelines give patients more EHR privacy control
• E-prescribing gets a boost
• King purchases Alpharma
• Merck divests vaccine lab
• GSK/Archemix deal
• Milestone payment
• Cancer's toll
• Specialty pharmacy
• Burr is chosen to serve as the chairman at Impax Labs
• Norrie Russell
• Matthew Fust
• HDMA appointments
• Melissa Murer Corrigan
• Compliance 'pays for itself'
• Former Lilly chairman on personalized care
• The economic imperatives are there
• Consolidation among pharmaceutical makers continues
• New program aims to build entrepreneurs
• Study eyes intravenous pain treatment
• APP launches heparin safety plan
• Neosalus is introduced
• Trilipix approved
• Prenatal vitamins
• Glivec approval
• Labopharm O.K
• Zolpimist approval
• Boostrix indication
• Perrigo given FDA O.K. for PL version of ibuprofen PM
• Fighting abuse
• Nicotine gum
• Foot spray
• Prostate cancer drug wins approval
• Antiepileptic drugs must bear warnings
• Antifungal therapy may ease asthma symptoms
• FDA clears growth aid for eyelashes
• Azathioprine available
• Annual meeting set
• Price battles slow worldwide sales growth
• Actavis agrees to FDA decree
• More generics receive regulatory clearance
• Teva wraps up Barr acquisition
• Report: biogenerics offer big savings
• D-T-C advertising: good for patients?
  by Robert Coopman
• Impact of price controls scrutinized

• 1
• 2